Drug recall · July 1, 2020
Clozapine Tablets USP tablet recall
Why: Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05
- Lots / codes
Lot #: CZSC20003-A, Exp 1/2022
- Quantity
- 1440 bottles
- Company
- Aurobindo Pharma USA Inc., East Windsor, NJ
- Distribution
- U.S.A. Nationwide
- Initiated
- June 12, 2020 · Voluntary: Firm initiated
- Classified
- June 30, 2020
- Reported
- July 1, 2020
- Ended
- December 21, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clozapine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.